To identify the putative mammalian hyaluronan synthase, we cloned a human cDNA that is related to the Streptococcus hyaluronan synthase (HasA) and the Xenopus developmental protein DG42 which has been shown to have chitin synthase activity. The cDNA, for which we propose the name Has2, encodes a novel protein with a predicted molecular mass of 63.6 kDa. Has2 shows 55% amino acid identity with Xenopus DG42 and 52% identity with the mouse HAS protein, another putative hyaluronan synthase recently reported by Itano and Kimata (Itano, N., and Kimata, K. (1996) J. Biol. Chem. 271, 9875-9878). The deduced primary structure revealed the presence of several hydrophobic stretches which can form multiple transmembrane domains. It also demonstrated the complete conservation of amino acid residues that are known to be critical for N-acetylglucosaminyltransferase activity of yeast chitin synthase. When the Has2 cDNA was transfected into human 293 and Chinese hamster ovary cells, the production of hyaluronan in the transfected cells increased up to 34-and 9-fold, respectively. Strong expression of Has2 mRNA was observed in exponentially proliferating human IMR-90 fibroblasts but not in growth-arrested IMR-90 cells. These results suggest that the Has2 protein is a crucial component of the human hyaluronan synthase system.
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Hyaluronan (HA)
1 is a glycosaminoglycan of alternating Nacetylglucosamine (GlcNAc) and glucuronic acid (GlcA) residues synthesized by essentially all organisms from bacteria to mammals. Several lines of evidence indicate that, unlike other glycosaminoglycans, the HA synthesis occurs at the inner surface of the plasma membrane with the growing HA chains extruding through pore-like structures into the extracellular space (1, 2). The structure of the Streptococcus HA synthase (HasA) appears to be consistent with this model of HA synthesis, since it has several hydrophobic stretches that could form multiple transmembrane domains (3) . Search of the sequence data base revealed that Rhizobium NodC gene, yeast chitin synthases, and the Xenopus developmental protein DG42 bear substantial similarities to HasA (4). We have hypothesized that the mammalian HA synthase is a member of this family of proteins and attempted to clone it by using the sequence homology between HasA and DG42. Here we report the identification of a novel member of this family named Has2 which has an activity to direct greatly increased HA synthesis in transfected cells.
EXPERIMENTAL PROCEDURES
cDNA Cloning-Double-stranded cDNA was synthesized from the mRNA isolated from IMR-90 human fibroblasts using a cDNA synthesis kit from Amersham. PCR was performed with the cDNA and oligonucleotide primers designed based on the amino acid homologies between HasA (3) and DG42 (5) . The combination of the following primers reproducibly amplified a fragment of expected size (130 bp); sense primer, 5Ј-GGIGA(T/C)GA(T/C)(A/C)GICA(T/C)(T/C)TIAC-3Ј (corresponding to amino acid sequences 233 GDDRCLT of HasA and 340 GD-DRHLT of DG42); antisense primer, 5Ј-TTI(G/T)TCCAIC(G/T)I(G/ T)T(C/T)TG(C/T)TG-3Ј (corresponding to amino acid sequences 270 QQNRWNK of HasA and 378 QQTRWTK of DG42). The nucleotide sequence of the amplified fragment was shown to have significant similarities to those of DG42 and HasA. A longer cDNA fragment was then amplified with a degenerate sense primer (5Ј-TA(C/T)TGGATG-GCNTT(C/T)AA(C/T)GTNGA-3Ј) corresponding to an upstream conserved region ( 260 YWMAFNIE in Fig. 1 ) and a nested antisense primer (5Ј-GGTTGCTGGTTTAGCCA-3Ј). The resulting 276-bp fragment was sequenced and used to screen a ZAP human brain stem cDNA library (Stratagene). Two clones, HFB1 and HFB2, were plaque-purified, from which corresponding plasmids, pHFB1 and pHFB2, were excised with helper phage. The insert cDNAs were sequenced as described previously (6) . Analysis for protein structures was performed by the PredictProtein (EMBL, Heidelberg) and the TMpred (Swiss Institute for Experimental Cancer Research, Lausanne) programs.
Construction of Epitope-tagged Has2 Expression Vector-The nucleotide sequence encoding the 12CA5 epitope sequence (YPYDVPDYA) (7) was introduced by PCR into the 3Ј end of the coding region. Briefly, a PCR fragment was amplified between nucleotide positions 2071 and 2191 with the following primers; sense primer, 5Ј-AATTGTTG-GAACGTTGCTC-3Ј; antisense primer, 5Ј-TCAGGCGTAATCTGGCA-CATCGTATGGGTATACATCAAGCACCATGTC-3Ј. (This primer contains antisense sequence for the 12CA5 epitope and a stop codon as indicated by single and double underlines, respectively.) The resulting PCR fragment includes a SphI site corresponding to the SphI site at nucleotide position 2097 of Has2 and sequences encoding the 12CA5 epitope and a stop codon. The PCR fragment was subcloned into pGEM-T (Promega), from which a 150-bp SphI fragment was excised at the SphI site in the PCR fragment and a single SphI site in the multiple cloning site of pGEM-T. Thus, the excised fragment consists of the nucleotides 2098 -2191 of Has2, the 12CA5 epitope, a stop codon, and a short segment (26 bp) of the multiple cloning site of pGEM-T. This fragment was then ligated into the SphI site (nucleotide position 2097) of pHFB1. The entire Has2 insert in this construct was excised and ligated to the mammalian expression vector pcDNA3 (Invitrogen, San Diego, CA) in sense orientation to generate pHAStagC.
Transfection and the Assay for HA Production-To establish stable transfectants, subconfluent human 293 cells in a 10-cm culture dish were transfected with 10 g of pHAStagC using Pharmacia CellPhect transfection kit and selected in the presence of 800 g/ml G418. Dihydrofolate reductase-deficient CHO-DG44 cells were co-transfected with 10 g of pHAStagC and 1 g of pSV2dhfr as described above and selected in nucleoside-free medium (8) and 400 g/ml G418. From each transfection, up to five resistant colonies were picked using cloning rings. Among them, three clones for each cell line were randomly selected for further studies (designated as 293pHAStagC-1, -2, and -3, * This work was supported by National Institutes of Health Grants HD 25938 and NS 32717 (to Y. Y.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The and CHOpHAStagC-1, -2, and -3). For the assay of HA production, 1 ϫ 10 5 cells were plated in a 35-mm well and cultured overnight. Then cells were fed with fresh media, and their culture supernatants were collected after a 24 h-incubation for assay. Quantities of HA produced by transient and stable transfectants were measured in the culture supernatants by the radiometric HA binding assay using Pharmacia HA Test kit (Pharmacia AB, Uppsala, Sweden) (3, 9) . Since most of the synthesized HA is secreted into cultured media (10, 11) , the amount of cellassociated HA was not determined.
Cell Fractionation-The 293pHAStagC-1 cells in a 10-cm culture dish were washed and detached with 50 mM Tris (pH 7.4) containing 0.15 M NaCl and 2.5 mM EDTA. Detached cells were pelleted, resuspended in 1.4 ml of 50 mM Tris (pH 8.0), and disrupted by sonication. A suspension of the disrupted cells was ultracentrifuged in a Beckman TLS rotor at 50,000 rpm for 45 min and the supernatant was collected. Pellets were dissolved in 0.5 ml of 1% SDS, followed by centrifugation at 14,000 ϫ g to remove insoluble materials. Amounts equivalent to 1/70 of each fraction were loaded in each lane of a 8 -16% gradient SDS-PAGE gel and analyzed by immunoblotting.
RESULTS
We obtained a probe for a putative human HA synthase by a series of PCRs with degenerate primers which were designed based on the sequence homology between HasA and DG42. By screening a human brain stem cDNA library with the probe, we obtained a clone HFB1 which contains a 3-kb insert covering the entire open reading frame. Complete sequencing of the HFB1 insert demonstrated that it encodes a novel protein of 552 amino acid residues and a calculated molecular mass of 63.6 kDa (Fig. 1) , for which we propose the name Has2. Alignment analyses showed that Has2 is 55% and 52% identical, respectively, to Xenopus DG42 (5) and the mouse HAS protein, another putative mouse HA synthase recently reported (12) . Analysis by PredictProtein and TMpred programs predicted 6 potential transmembrane helices, 2 in the N-terminal and 4 in the C-terminal regions. Both programs predicted a type II transmembrane topology for the N terminus of the protein.
Between the N-terminal and C-terminal regions, there is a long sequence without potential transmembrane domains. In this region, residues that are thought to be crucial for N-acetylglucosaminyltransferase activity of chitin synthase 2 (13) are completely conserved (Fig. 2) .
To demonstrate the enzyme activity of the protein, we transfected the Has2 cDNA into human 293 and CHO cells. Expression of the recombinant protein was verified by immuno- 
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blotting with 12CA5 monoclonal antibodies (Boehringer Mannheim) which recognize the epitope tag. Quantitation of HA production demonstrated that randomly selected 293 transfectant clones produce HA up to 34-fold higher than the HA production by control transfected and untransfected 293 cells (Table I) . In CHO cells where the background production of HA is much lower than that of 293 cells, HA production by transfectants was still significantly greater (up to 9-fold) than that of control cells (Table I) .
Like DG42, the deduced primary structure of Has2 predicts multiple hydrophobic stretches that may serve as transmembrane domains. However, Rosa et al. (5) reported that a large proportion of DG42 in Xenopus embryo is solubilized in physiological buffers without any detergents. To examine the subcellular distribution of Has2, stably transfected cells were fractionated by ultracentrifugation and the distribution of Has2 in these fractions was analyzed by immunoblotting with 12CA5 antibodies (Fig. 3A) . This experiment demonstrated that a minor portion (ϳ30%) of Has2 is present in the supernatant fraction, which mainly consists of cytosol. Nevertheless, the majority of Has2 was fractionated into the pellet, which contains membranes. To rule out the possibility that this was due to incomplete extraction, we examined the distribution of BAG-1, a Bcl-2 binding cytosolic protein (14) , in the same samples. As shown in Fig. 3B , BAG-1 was completely extracted into the supernatant. These results confirmed that the majority of Has2 is indeed associated with cell membranes as predicted from its sequence. It is not clear at present whether the Has2 detected in the supernatant fraction, which migrates slightly slower in SDS-PAGE than the membrane-associated Has2 (see Fig. 3A ), represents a biochemically distinct population.
In Northern blotting analysis, two Has2 mRNA species of 4.4 kb and 2.5 kb in size were detected in exponentially proliferating IMR-90 fibroblasts (Fig. 4) . Quiescent IMR-90 cells at confluency do not express detectable levels of Has2 mRNA.
DISCUSSION
Has2 is a novel member of the family that includes HasA (3), yeast chitin synthases (15) , NodC (16) , and DG42 (5). Although not originally identified as enzymes, NodC and DG42 have been shown to catalyze synthesis of chitin-like oligosaccharides (17) (18) (19) . HA and chitin are structurally related, while HA is a repeating disaccharide polymer of GlcA(␤133) GlcNAc(␤134) residues, chitin is a homopolymer of GlcNAc(␤134). Therefore, these proteins have ␤-N-acetylglucosaminyltransferase activity in common.
The overall structure of Has2 with its multiple potential transmembrane domains is strikingly similar to the other members of the family, yet the similarity is not only in the overall structure. Nagahashi et al. (13) have identified 5 amino acid residues that are crucial for the ␤-N-acetylglucosaminyltransferase activity of Saccharomyces chitin synthase 2 and found that these residues are conserved in the members of the family including HasA, NodC, and DG42. Remarkably, these residues are also completely conserved in Has2 (Fig. 2) . This strongly suggests that Has2 has at least ␤-N-acetylglucosaminyltransferase activity.
Comparison of amino acid sequences showed that while Has2 and the HAS protein (12) are distinct molecular entities, they are similarly distant from Xenopus DG42. On the other hand, the zebra fish and mouse "DG42-like" cDNAs, for which partial sequences have been reported by Semino et al. (20) , are essentially identical to the corresponding region of Has2 (93% and 100% identical, respectively). These data suggest that Has2, Electrophoresis, blot transfer, and hybridization were performed as described previously (6) . Human Hyaluronan Synthase 22947 the HAS protein, and DG42 represent three distinct molecular entities of the family, whereas the zebra fish and mouse DG42-like cDNAs (20) are likely to be the homologues of Has2. We showed that, upon transfection, Has2 confers a greatly increased production of HA to cells. Furthermore, the expression pattern of Has2 mRNA in confluent and proliferating fibroblasts is consistent with the reported pattern of HA synthesis in these cells; the synthesis of HA increases in proliferating fibroblasts while it is inhibited in growth-arrested cells (21) (22) (23) . Thus, taken together with the aforementioned structural similarities, these results strongly suggest that Has2 is a crucial component of the human HA synthase system if not the HA synthase per se. Although our data have not ruled out the possibility that Has2 is an activator or inducer of true HA synthase, this wealth of circumstantial evidence appears to indicate otherwise.
In any event, the enzymatic properties of Has2 should be thoroughly examined in future studies to definitely prove that Has2 is the authentic hyaluronan synthase. A most critical question is whether Has2 alone is capable of synthesizing high molecular mass HA. Although studies on bacterial HA synthesis demonstrated that HasA is the sole component required for a functional HA synthase (24), it is not known whether the same is true for the mammalian system. Finally, it is important to determine how Has2 associates with cell membranes and whether the membrane association is required for its activity. Our finding that Has2 is present in a cytosolic fraction as well as in membranes suggests the possibility that HA synthesis in mammalian cells could be regulated by a dynamic interaction of Has2 with cell membranes.
